home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 24, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 584 active entries

Cell Therapies Pty Ltd

Ground Floor 10 St Andrew's Place
East Melbourne, 3002

Phone: +61 (0)3 9656 5804
Fax: +61 (0)3 9656 1650

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Cell Therapies Pty Ltd is a contract service provider supporting cell therapy clinical trials and commercial manufacture of human cells and tissue. A fully-integrated range of services covers all aspects of cell therapy manufacture, including production in compliance with Good Manufacturing Practices (cGMP), under TGA, EMA and FDA regulatory controls.

Services include:

• Protocol design, validation and approvals
• SOP preparation
• Recruitment of investigators and patients

• Cell collection and logistics
• Process and analytical development, validation
• GMP manufacturing and QC testing (licensed facility)

• Cell therapy product administration
• Clinical interpretation and reporting
• Audit compliance

Based in the Peter MacCallum Cancer Centre and the Centre for Blood Cell Therapies, Cell Therapies can provide a one-stop shop for cell therapy trials or commercial manufacture. Our capacity to work with a wide range of cell types and clinical conditions has proven to be a powerful attraction for our clients. We can recruit patients from within our cancer related facility and/or in collaboration with other clinical sites., We deliver reliable trial results under demanding protocol and reporting regimens.

Other resources at the Peter MacCallum Cancer Centre can be incorporated into clinical studies as well. A state of the art Diagnostic Imaging suite, for example, offers clinical and research PET, MRI, CT, SPECT, combined PET-CT, and Ultrasound imaging capabilities. Our state of the art work with custom cell labelling, permitting in vivo tracking of administered cells can be particularly useful in answering biodistribution questions from regulatory authorities.

Selected Categories:
Product Company   Service Company
- Research
- Research
- Research
- Research
- Production
- Research
- Services

Last update of this entry: October 26, 2011

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.